ABSTRACT
Background Prolonged past exposure to secondhand tobacco smoke (SHS) is associated with exercise limitation. Pulmonary factors including air trapping contribute to this limitation but the contribution of cardiovascular factors is unclear.
Methods To determine contribution of cardiovascular mechanisms to SHS-associated exercise limitation, we examined the cardiovascular responses to maximum effort exercise testing in 166 never-smokers with remote but prolonged occupational exposure to SHS and no known history of cardiovascular disease except nine with medically-controlled hypertension. We estimated the contribution of oxygen-pulse (proxy for cardiac stroke volume) and changes in systolic (SBP) and diastolic blood pressures (DBP) and heart rate (HR) over workload towards exercise capacity, and examined whether the association of SHS with exercise capacity was mediated through these variables.
Results Oxygen consumption (VO2Peak) and oxygen-pulse (O2-PulsePeak) at peak exercise were 1,516±431mL/min (100±23 %predicted) and 10.6±2.8mL/beat (117±25 %predicted), respectively, with 91 (55%) and 43 (26%) of subjects not being able to achieve their maximum predicted values. Sixty-two percent showed hypertensive response to exercise by at least one established criterion. In adjusted models, VO2Peak was associated directly with O2-Pulse and inversely with rise of SBP and DBP over workload (all P<0.05). Moreover, SHS exposure association with VO2Peak was mainly (84%) mediated through its effect on oxygen-pulse (P=0.034). Notably, although not statistically significant, a large proportion (60%) of air trapping effect on VO2Peak seemed to be mediated through oxygen-pulse (P=0.066).
Discussion In a never-smoker population with remote prolonged exposure to SHS, abnormal escalation of afterload and an SHS-associated reduction in cardiac output contributed to lower exercise capacity.
Competing Interest Statement
This work was supported by: 1.Flight Attendant Medical Research Institute (FAMRI) (012500WG and CIA190001 to MA). 2.California Tobacco-Related Disease Research Program (TRDRP) (T29IR0715 to MA). 3.The Department of Veterans Affairs (CXV-00125 to MA). 4.National Library of Medicine Training Grant (NIH: T15LM007442 to SZ) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The statements and conclusions in this publication are those of the authors and not necessarily those of the funding agency. The mention of commercial products, their source, or their use in connection with the material reported herein is not to be construed as an actual or implied endorsement of such products.
Funding Statement
This work was supported by: 1.Flight Attendant Medical Research Institute (FAMRI) (012500WG and CIA190001 to MA). 2.California Tobacco-Related Disease Research Program (TRDRP) (T29IR0715 to MA). 3.The Department of Veterans Affairs (CXV-00125 to MA). 4.National Library of Medicine Training Grant (NIH: T15LM007442 to SZ)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UCSF Institutional Review Board (IRB) and the San Francisco VA Medical Center Committee on Research and Development approved study protocols. Written IRB-approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) were obtained from all study participants. Subjects received monetary compensation for their participation in the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors’ Contributions Conceived and designed the current manuscript study: MA Developed study protocols: WMG, MA Collected samples and data: SZ, MD, JB, WMG, MA Analyzed and interpreted data: SZ, MD, JB, JK, MA Prepared and edited the manuscript: SZ, MD, JB, WMG, MA Obtained funding: MA
Summary conflict of interest: Authors report no conflict of interest related to this work
Footnote This work was supported by:
Flight Attendant Medical Research Institute (FAMRI) (012500WG and CIA190001 to MA).
California Tobacco-Related Disease Research Program (TRDRP) (T29IR0715 to MA).
The Department of Veterans Affairs (CXV-00125 to MA).
National Library of Medicine Training Grant (NIH: T15LM007442 to SZ)
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The statements and conclusions in this publication are those of the authors and not necessarily those of the funding agency. The mention of commercial products, their source, or their use in connection with the material reported herein is not to be construed as an actual or implied endorsement of such products.
Notation of prior abstract publication/presentation: Some of the results of this study have been previously reported in the form of an abstract (American Thoracic Society International Meeting 2020: Am J Respir Crit Care Med 2020;201:A7591)
Data Availability
Data
- Abbreviation list:
- COPD
- Chronic obstructive pulmonary disease
- CT
- Computerized tomography
- DM
- Density mask
- EELV
- End-expiratory lung volume
- EFL
- Expiratory flow limitation
- FAMRI
- Flight Attendant Medical Research Institute
- FEF25-75
- Forced expiratory flow at 25% to 75% of FVC
- FEF75
- Forced expiratory flow at 75% of FVC
- FEV1
- Forced expiratory volume in 1 second
- FVC
- Forced vital capacity
- GLI
- Global Lung Function Initiative
- GOLD
- Global Initiative on Obstructive Lung Disease
- HU
- Hounsfield unit
- IC
- Inspiratory capacity
- LLN
- Lower limit of normal
- MEF
- Maximum expiratory flow
- PFT
- Pulmonary function test
- RV
- Residual volume
- SHS
- Secondhand tobacco smoke
- TLC
- Total lung capacity
- VE
- Minute ventilation
- VFL
- Volume of the tidal breath that is flow-limited on expiration
- VO2Max
- Maximum oxygen uptake
- VT
- Tidal volume
- WattsMax
- Maximum work achieved in watts